These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). WHO Expert Group Vox Sang; 2012 Nov; 103(4):337-42. PubMed ID: 22690746 [TBL] [Abstract][Full Text] [Related]
3. Hemovigilance in developing countries. Ayob Y Biologicals; 2010 Jan; 38(1):91-6. PubMed ID: 20133151 [TBL] [Abstract][Full Text] [Related]
4. Developing an administrative plan for transfusion medicine--a global perspective. Sullivan P Transfusion; 2005 Oct; 45(4 Suppl):224S-40S. PubMed ID: 16181405 [TBL] [Abstract][Full Text] [Related]
6. [European Blood Alliance (EBA) and EuroNet TMS: what challenges for the transfusion of tomorrow?]. Folléa G; de Wit J; Rouger P Transfus Clin Biol; 2011 Apr; 18(2):106-14. PubMed ID: 21458349 [TBL] [Abstract][Full Text] [Related]
8. The organization and operation of blood transfusion services in Andalusia. Rotllán JG Transfus Sci; 1992 Apr; 13(2):211-9. PubMed ID: 10148128 [TBL] [Abstract][Full Text] [Related]
9. Strengthening the service continuum between transfusion providers and suppliers: enhancing the blood services network. Sime SL Transfusion; 2005 Oct; 45(4 Suppl):206S-23S. PubMed ID: 16181404 [TBL] [Abstract][Full Text] [Related]
10. [Transfusion medicine in unified Europe]. Grigutsch V Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():12-5. PubMed ID: 7841774 [TBL] [Abstract][Full Text] [Related]
11. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS. Mahony BO; Turner A Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697 [No Abstract] [Full Text] [Related]
13. The European Blood Directive--its role in blood safety. Seitz R Dev Biol (Basel); 2007; 127():147-52. PubMed ID: 17486887 [TBL] [Abstract][Full Text] [Related]
14. ISBT Board response to the Dublin consensus statement. Flanagan P Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536 [No Abstract] [Full Text] [Related]
15. Transposition of the Blood Directive into national law--the perspective of Portugal. Gonçalves MH; Muon MC; Gonçalves Jd Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287 [TBL] [Abstract][Full Text] [Related]
16. [Blood transfusion safety in a limited resources setting: the elaboration of a rational National Blood Policy in Togo]. Sodahlon YK; Segbena AY; Prince-David M; Gbo KA; Fargier MP; North ML; Malvy DJ Sante; 2004; 14(2):115-20. PubMed ID: 15454371 [TBL] [Abstract][Full Text] [Related]
17. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. Lackritz EM AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988 [TBL] [Abstract][Full Text] [Related]
18. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries. Rovira J Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921 [No Abstract] [Full Text] [Related]
19. Blood transfusion services: organization is integral to safety. Nanu A Natl Med J India; 2001; 14(4):237-40. PubMed ID: 11547532 [TBL] [Abstract][Full Text] [Related]
20. International challenges of self-sufficiency in blood products. Dhingra N Transfus Clin Biol; 2013 May; 20(2):148-52. PubMed ID: 23643329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]